Neuroprotective effects of resveratrol against Aβ administration in rats are improved by lipid-core nanocapsules (Q48212922)

9 February 2018

title

Neuroprotective effects of resveratrol against Aβ administration in rats are improved by lipid-core nanocapsules (English)

1 reference

9 February 2018

author

Adriana R. Pohlmann

7

1 reference

9 February 2018

Ana Maria Oliveira Battastini

6

object named as

Ana M O Battastini

1 reference

9 February 2018

Rudimar L Frozza

1

object named as

Rudimar L Frozza

1 reference

9 February 2018

author name string

Andressa Bernardi

2

1 reference

9 February 2018

Juliana B Hoppe

3

1 reference

9 February 2018

André B Meneghetti

4

1 reference

9 February 2018

Aline Matté

5

1 reference

9 February 2018

Sílvia S Guterres

8

1 reference

9 February 2018

Christianne Salbego

9

1 reference

9 February 2018

publication date

12 January 2013

1 reference

9 February 2018

published in

Molecular Neurobiology

1 reference

9 February 2018

volume

47

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

1066-1080

1 reference

9 February 2018

Pathways towards and away from Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Deciphering the molecular basis of memory failure in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

The blood-brain barrier: bottleneck in brain drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Nanotechnological applications for the treatment of neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Biodegradable polymeric nanoparticles as drug delivery devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Delivery of peptide and protein drugs over the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Influence of benzyl benzoate as oil core on the physicochemical properties of spray-dried powders from polymeric nanocapsules containing indomethacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Alkaline hydrolysis as a tool to determine the association form of indomethacin in nanocapsules prepared with poly(eta-caprolactone).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer's disease models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Therapeutic potential of resveratrol in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Resveratrol--a boon for treating Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Resveratrol: a multitargeted agent for age-associated chronic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Metabolism and bioavailability of trans-resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Administration of resveratrol: What formulation solutions to bioavailability limitations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Review of the folin phenol protein quantitation method of lowry, rosebrough, farr and randall

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Protective effect of resveratrol against oxygen-glucose deprivation in organotypic hippocampal slice cultures: Involvement of PI3-K pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Dendritic spine loss and synaptic alterations in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Object recognition memory and the rodent hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Role of the macrophage inflammatory protein-1alpha/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Effects of indomethacin-loaded nanocapsules in experimental models of inflammation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Protective effects of indomethacin-loaded nanocapsules against oxygen-glucose deprivation in organotypic hippocampal slice cultures: involvement of neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Pleiotropic mechanisms facilitated by resveratrol and its metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Bioavailability of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Microglia activation and anti-inflammatory regulation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

JNK: A Stress-Activated Protein Kinase Therapeutic Strategies and Involvement in Alzheimer’s and Various Neurodegenerative Abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Neurodegenerative and physiological actions of c-Jun N-terminal kinases in the mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Glycogen synthase kinase 3beta and Alzheimer's disease: pathophysiological and therapeutic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Wnt signaling: a common theme in animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Synaptotoxicity in Alzheimer's disease: the Wnt signaling pathway as a molecular target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

The binding of resveratrol to monomer and fibril amyloid beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Resolving controversies on the path to Alzheimer's therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Neurotoxicity of amyloid β-protein: synaptic and network dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8401-2

Animal models of Alzheimer's disease: therapeutic implications.

21 January 2018

1 reference

12 December 2020

Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1

1 reference

12 December 2020

JNK plays a key role in tau hyperphosphorylation in Alzheimer's disease models.

1 reference

12 December 2020

Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area

1 reference

12 December 2020

Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)

1 reference

12 December 2020

A local Wnt-3a signal is required for development of the mammalian hippocampus

1 reference

12 December 2020

Dexamethasone-loaded nanoparticle-coated microparticles: Correlation between in vitro drug release and drug transport across Caco-2 cell monolayers

1 reference

12 December 2020

Determining the simultaneous presence of drug nanocrystals in drug-loaded polymeric nanocapsule aqueous suspensions: A relation between light scattering and drug content

1 reference

12 December 2020

Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area

1 reference

12 December 2020

Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway.

1 reference

12 December 2020

10.1007/S12035-013-8401-2

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018